Gene description
Orthologous
GO biological process
leucine biosynthetic process, response to salt stress, glucosinolate biosynthetic process, oxidation-reduction process
GO cellular component
chloroplast, chloroplast stroma, cytoplasm, plastid
GO molecular function
NAD binding, oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor, 3-isopropylmalate dehydrogenase activity, magnesium ion binding
Metabolic pathway
KEGG pathway
Transcriptional regulation
Regulator:
AT5G13790, AT4G18770, AT2G20180, AT5G61850, AT4G36990
Target:
none
Coexpression network
Differentially expressed condition
13 conditions
Series | Control | Treatment | Log2FC | Adj. P value |
---|---|---|---|---|
GSE37269 | Ei2, WT, control | Ei2, WT, TEV 21 d | -2.15 | 5.50E-04 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 12 h | -2.50 | 3.25E-08 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 12 h | -2.45 | 4.71E-08 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 4 h | -1.85 | 2.09E-06 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 8 h | -2.94 | 2.97E-09 |
GSE45214 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 4 h | -1.69 | 1.72E-09 |
GSE45214 | Col, med16, PstDC3000 AvrRpt2 0 h | Col, med16, PstDC3000 AvrRpt2 4 h | -1.54 | 3.52E-09 |
GSE56094 | Col, WT, control 10 h | Col, WT, PstDC3000 10 h | -3.36 | 6.10E-14 |
GSE56094 | Col, WT, control 10 h | Col, WT, hrpA- 10 h | -1.62 | 2.55E-04 |
GSE56094 | Col, WT, control 11 h | Col, WT, PstDC3000 11 h | -2.05 | 1.40E-06 |
GSE56094 | Col, WT, control 12 h | Col, WT, PstDC3000 12 h | -2.58 | 2.61E-09 |
GSE56094 | Col, WT, control 13 h | Col, WT, PstDC3000 13 h | -2.74 | 2.70E-10 |
GSE56094 | Col, WT, control 9 h | Col, WT, PstDC3000 9 h | -1.55 | 2.92E-04 |
Copyright © 2017 Ziding Zhang's Lab - China Agricultural University. All Rights Reserved.